Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2025-12-25 @ 4:16 AM
NCT ID:
NCT00953420
Eligibility Criteria:
INCLUSION CRITERIA:
* Nasopharyngeal Carcinoma in first or subsequent relapse or with primary refractory disease in whom the EBV-genome or antigens have been demonstrated in tissue biopsy samples
* Age 10 years or older
* Life expectancy of 8 weeks or more
* Karnofsky or Lansky score of 50 or more
* Normal bilirubin level (per institutional standard)
* AST and ALT 1.5 x or less upper limit of normal
* Alk Phos level less than 2.5 x upper limit of normal
* ANC greater than 1500 cells/ul
* Hgb 8.0 or greater
* Platelets 100,000 cells/ul or more
* Creatinine 2 x or less ULN or GFR 50 ml/min/1.73 m2 or more
* Women of child-bearing potential must take/use effective birth control while participating in the study.
EXCLUSION CRITERIA:
* Due to the unknown effects of this therapy on a fetus, pregnant women will be excluded from this research.
* Prior allergic reaction to the study drugs used in this protocol or other drugs formulated with polysorbate 80.
* Known HIV positive subjects since treatment may be significantly immunosuppressive
* Women who are breast-feeding
* Severe intercurrent infection
* Patients, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Study:
NCT00953420
Study Brief:
Protocol Section:
NCT00953420